like I said, most other small biotech start-up/ turn-a-round companies are in same scenario, except bmsn has much more potential. at times frustration can set in ,as patience can, at times grow thin. but when one looks back at the company's timelines, with their p.r. 's back in april, they are still on track . of course ,with your past experience with these kinds of investments, you already knew this by doing your d.d before you bought in here. I have been accumulating now going on 9 months, and currently hold 20 million shares. ready to take this for a ride right into early retirement.